Vipera Berus Venom
US-FDASourced from openFDA
GET
/api/v1/drug/vipera-berus-venomIndications
Sourced from openFDA- Relieves painful legs improved by elevation * See symptoms on front panel.
Dosage & administration
Sourced from openFDAAdults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
FAERS reports
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
486 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
- 1Diarrhoea336.8%
- 2Pain336.8%
- 3Headache306.2%
- 4Fatigue296.0%
- 5Nausea275.6%
- 6Arthralgia265.3%
- 7Dizziness255.1%
- 8Pain In Extremity214.3%
- 9Asthenia183.7%
- 10Abdominal Pain Upper173.5%
- 11Eye Pain173.5%
- 12Fall173.5%
- 13Gait Disturbance173.5%
- 14Muscle Spasms173.5%
- 15Dyspnoea163.3%
Literature
Recent PubMed references pinned to Vipera Berus Venom as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- [Evaluation of the Efficacy and Tolerance of Tranexamic Acid Combined with Inoserp(TM) PAN-AFRICA Antivenom in the Treatment of Hemorrhagic Syndrome during Envenomation by Echis ocellatus in Benin].Medecine tropicale et sante internationale · 2026 · Larréché S, Sodjinou N, Tourita N, et al.PMID 42221451DOI 10.48327/mtsi.v6i1.2026.745
- Bothrops jararaca snake venom: A reappraisal of its coagulant activity in humans, mice, and rats.PLoS neglected tropical diseases · 2026 · Torres AV, Penas Picon NT, Ferreira de Oliveira N, et al.PMID 42189852DOI 10.1371/journal.pntd.0014335
- Preliminary Insights into Geographic Variation in Venom Profiles and Functional Activities of Nigerian Snakes, Bitis arietans and Naja nigricollis.Toxins · 2026 · Adeyi AO, Emmanuel OS, Itang SI, et al.PMID 42188623DOI 10.3390/toxins18050221
- Azemiops feae (Fea's Viper) Envenoming: A Case Report and Review of the Literature.Toxins · 2026 · Qiao Z, Tang Y, Zhou Q, et al.PMID 42188604DOI 10.3390/toxins18050201
- Venom with an altitude: Coagulopathy following an envenomation by the high-mountain snake Gloydius monticola (Likiang pitviper) in Yunnan Province, China.Toxicon : official journal of the International Society on Toxinology · 2026 · Qiao Z, Tang Y, Liu C, et al.PMID 42128184DOI 10.1016/j.toxicon.2026.109150
- First Clinical Report on Efficacy of Alternative European Viper Antivenoms in Treatment of Vipera ammodytes Envenomation in Croatia.Toxins · 2026 · Čikeš Šimunković M, Leonardi A, Križaj I, et al.PMID 42043042DOI 10.3390/toxins18040178
- Differential Hematotoxic Activity of Southeast Asian Pit Viper Venoms: The Cross-Neutralizing Effect of Available Antivenoms.Medical sciences (Basel, Switzerland) · 2026 · Apipongrat D, Ahmad Rusmili MR, Thapanasopon K, et al.PMID 42029623DOI 10.3390/medsci14020199
- Brugada phenocopy induced by Russell's viper envenomation: resolution following anti-snake venom therapy.BMJ case reports · 2026 · Rao P SK, J Patel H, Bammigatti C, et al.PMID 42014161DOI 10.1136/bcr-2025-271876
Frequently asked questions
- What is Vipera Berus Venom used for?
- According to FDA labeling, Vipera Berus Venom carries indications including: Relieves painful legs improved by elevation * See symptoms on front panel.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
Note. Data for
vipera-berus-venom is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.